Medicare Enrolled
Dr. Virendra Patel, M.D.
Nuclear Cardiology Physician · Brick, NJ
Practice pattern: Cardiac & Electrophysiology
— Practice combining cardiac and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Patel
Dr. Virendra Patel is a nuclear cardiology physician in Brick, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Patel performed 5,308 Medicare services across 3,138 unique beneficiaries.
Between the years covered by Open Payments, Dr. Patel received a total of $6,686 from 37 pharmaceutical and/or device companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nuclear cardiology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 14% volume in NJ
$6,686 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,308
Medicare services
Top 14% in NJ for nuclear cardiology physician
3,138
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~265 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,099 | $11 | $115 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
962 | $97 | $230 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
600 | $44 | $75 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
592 | $66 | $286 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
296 | $9 | $32 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
285 | $164 | $1,480 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
243 | $53 | $530 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
234 | $69 | $91 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
229 | $386 | $2,535 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
150 | $65 | $160 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
133 | $144 | $645 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
72 | $19 | $90 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
72 | $31 | $170 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
69 | $100 | $410 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
68 | $142 | $284 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
67 | $118 | $420 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
62 | $58 | $635 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
34 | $16 | $25 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
21 | $42 | $143 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
20 | $179 | $962 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.4% high complexity
24.6% medium
70.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,686
Total received (2018-2024)
Avg $955/year across 7 years
Top 39% in NJ for nuclear cardiology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
386
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,487 (97.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$198 (3.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,416
2023
$1,156
2022
$813
2021
$825
2020
$405
2019
$1,197
2018
$874
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$286
Amgen Inc.
$203
Novartis Pharmaceuticals Corporation
$148
Neurelis, Inc.
$121
PFIZER INC.
$97
ABIOMED
$87
Merck Sharp & Dohme LLC
$79
Boston Scientific Corporation
$66
Boehringer Ingelheim Pharmaceuticals, Inc.
$55
Abbott Laboratories
$52
Kiniksa Pharmaceuticals International, plc
$49
Novo Nordisk Inc
$49
Janssen Pharmaceuticals, Inc
$36
Lexicon Pharmaceuticals, Inc.
$29
Esperion Therapeutics, Inc.
$28
Smith+Nephew, Inc.
$18
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 44.9% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$799
Amgen Inc.
$673
Janssen Pharmaceuticals, Inc
$584
Novartis Pharmaceuticals Corporation
$528
PFIZER INC.
$464
SANOFI-AVENTIS U.S. LLC
$389
Boston Scientific Corporation
$326
Abbott Laboratories
$300
Boehringer Ingelheim Pharmaceuticals, Inc.
$262
AstraZeneca Pharmaceuticals LP
$237
Amarin Pharma Inc.
$201
ABIOMED
$182
Merck Sharp & Dohme LLC
$166
BOSTON SCIENTIFIC CORPORATION
$127
Allergan Inc.
$124
Neurelis, Inc.
$121
ARBOR PHARMACEUTICALS, INC.
$111
Regeneron Healthcare Solutions, Inc.
$108
Kowa Pharmaceuticals America, Inc.
$105
Acorda Therapeutics, Inc
$103
InfoBionic, Inc
$99
Gilead Sciences, Inc.
$97
Medtronic, Inc.
$95
Esperion Therapeutics, Inc.
$82
Lexicon Pharmaceuticals, Inc.
$57
Kiniksa Pharmaceuticals International, plc
$49
Novo Nordisk Inc
$49
Merck Sharp & Dohme Corporation
$43
Cook Medical LLC
$35
Smith+Nephew, Inc.
$35
W. L. Gore & Associates, Inc.
$35
Kiniksa Pharmaceuticals, Ltd.
$28
BIOTRONIK INC.
$19
Amryt Pharma Holdings Ltd
$14
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$14
Lundbeck LLC
$12
Astellas Pharma US Inc
$11
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
AVEIR · Arcalyst · BRILINTA · Bone Anchors with Arthroscopic Delivery System · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · COLLAGENASE SANTYL · Confirm Rx · Cook Medical AAA · Corlanor · DALVANCE · ELIQUIS · ENDURANT IIS · ENTRESTO · Edarbi · Edarbyclor · Edora · FARXIGA · HeartMate · INBRIJA · Impella · Inpefa · JARDIANCE · JUXTAPID · LEQVIO · LEXISCAN · LYNPARZA · LifeVest · Livalo · MULTAQ · Mitra Clip system · MoMe Kardia · NEXLETOL · NORTHERA · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Allure MP RF CRT Pacemkr · RESONATE · Repatha · VALTOCO · VERQUVO · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · Wegovy · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Nuclear cardiology physicians within 10 mi
8
Per 100K population
1.2
County median income
$86,411
Nearest hospital
OCEAN MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Patel is a cardiac & electrophysiology specialist, with above-average Medicare volume (top 14% in NJ), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Patel experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Patel performed 1,099 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $6,686 from 37 companies across 386 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other nuclear cardiology physicians in Brick?
Dr. Patel's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Nuclear Cardiology Physicians in Brick
Browse nuclear cardiology physicians in Brick ranked by procedure volume and transparency data.
Highest volume
Top Nuclear Cardiology Physicians in NJ
Nuclear cardiology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nuclear Cardiology Physicians in NJ
Which NJ nuclear cardiology physicians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology